Abstract P3-11-09: ARISTACAT - Aromatase inhibition plus minus saracatinib as advanced breast cancer therapy: A randomised phase II study of aromatase inhibition plus/minus the Src-inhibitor AZD0530 in post-menopausal women with advanced breast cancer

Cameron, D., Symeonides, S., Brunt, M. et al. (10 more authors) (2020) Abstract P3-11-09: ARISTACAT - Aromatase inhibition plus minus saracatinib as advanced breast cancer therapy: A randomised phase II study of aromatase inhibition plus/minus the Src-inhibitor AZD0530 in post-menopausal women with advanced breast cancer. In: Cancer Research. 2019 San Antonio Breast Cancer Symposium, 10-14 Dec 2019, San Antonio, Texas, USA. American Association for Cancer Research. Article no: P3-11-09. ISSN: 0008-5472. EISSN: 1538-7445.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Cameron, D.
  • Symeonides, S.
  • Brunt, M.
  • Schmid, P.
  • Waters, S.
  • Twelves, C.
  • Barrett-Lee, P.
  • Bartlett, J.
  • Piper, T.
  • McAdam, K.
  • Chisholm, E.M.
  • Welsh, M.
  • Hill, R.
Dates:
  • Published: 15 February 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 27 Oct 2025 11:13
Last Modified: 27 Oct 2025 11:13
Status: Published
Publisher: American Association for Cancer Research
Identification Number: 10.1158/1538-7445.sabcs19-p3-11-09
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)